165 related articles for article (PubMed ID: 17276887)
1. Antiangiogenic activity of Diallyl Sulfide (DAS).
Thejass P; Kuttan G
Int Immunopharmacol; 2007 Mar; 7(3):295-305. PubMed ID: 17276887
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of endothelial cell differentiation and proinflammatory cytokine production during angiogenesis by allyl isothiocyanate and phenyl isothiocyanate.
Thejass P; Kuttan G
Integr Cancer Ther; 2007 Dec; 6(4):389-99. PubMed ID: 18048887
[TBL] [Abstract][Full Text] [Related]
3. (+)-Catechin inhibits tumour angiogenesis and regulates the production of nitric oxide and TNF-alpha in LPS-stimulated macrophages.
Guruvayoorappan C; Kuttan G
Innate Immun; 2008 Jun; 14(3):160-74. PubMed ID: 18562575
[TBL] [Abstract][Full Text] [Related]
4. Piper longum inhibits VEGF and proinflammatory cytokines and tumor-induced angiogenesis in C57BL/6 mice.
Sunila ES; Kuttan G
Int Immunopharmacol; 2006 May; 6(5):733-41. PubMed ID: 16546703
[TBL] [Abstract][Full Text] [Related]
5. Effect of Tinospora cordifolia on the cytokine profile of angiogenesis-induced animals.
Leyon PV; Kuttan G
Int Immunopharmacol; 2004 Dec; 4(13):1569-75. PubMed ID: 15454110
[TBL] [Abstract][Full Text] [Related]
6. Vernolide-A inhibits tumour specific angiogenesis by regulating proinflammatory cytokines, VEGF, MMPs and TIMP.
Pratheeshkumar P; Kuttan G
Eur J Pharmacol; 2011 Apr; 656(1-3):10-8. PubMed ID: 21256125
[TBL] [Abstract][Full Text] [Related]
7. Antiangiogenic activity of Andrographis paniculata extract and andrographolide.
Sheeja K; Guruvayoorappan C; Kuttan G
Int Immunopharmacol; 2007 Feb; 7(2):211-21. PubMed ID: 17178389
[TBL] [Abstract][Full Text] [Related]
8. Nomilin inhibits tumor-specific angiogenesis by downregulating VEGF, NO and proinflammatory cytokine profile and also by inhibiting the activation of MMP-2 and MMP-9.
Pratheeshkumar P; Kuttan G
Eur J Pharmacol; 2011 Oct; 668(3):450-8. PubMed ID: 21839074
[TBL] [Abstract][Full Text] [Related]
9. Beta-carotene inhibits tumor-specific angiogenesis by altering the cytokine profile and inhibits the nuclear translocation of transcription factors in B16F-10 melanoma cells.
Guruvayoorappan C; Kuttan G
Integr Cancer Ther; 2007 Sep; 6(3):258-70. PubMed ID: 17761639
[TBL] [Abstract][Full Text] [Related]
10. Harmine inhibits tumour specific neo-vessel formation by regulating VEGF, MMP, TIMP and pro-inflammatory mediators both in vivo and in vitro.
Hamsa TP; Kuttan G
Eur J Pharmacol; 2010 Dec; 649(1-3):64-73. PubMed ID: 20858484
[TBL] [Abstract][Full Text] [Related]
11. 13 cis-retinoic acid regulates cytokine production and inhibits angiogenesis by disrupting endothelial cell migration and tube formation.
Guruvayoorappan C; Kuttan G
J Exp Ther Oncol; 2008; 7(3):173-82. PubMed ID: 19066126
[TBL] [Abstract][Full Text] [Related]
12. Antiangiogenic activity of ursolic acid.
Kanjoormana M; Kuttan G
Integr Cancer Ther; 2010 Jun; 9(2):224-35. PubMed ID: 20462855
[TBL] [Abstract][Full Text] [Related]
13. Anti-angiogenic activity of Ipomoea obscura extract and Ipobscurine-A.
Hamsa TP; Kuttan G
Immunopharmacol Immunotoxicol; 2011 Sep; 33(3):488-97. PubMed ID: 21058930
[TBL] [Abstract][Full Text] [Related]
14. Anti-angiogenic effect of Biophytum sensitivum is exerted through its cytokine modulation activity and inhibitory activity against VEGF mRNA expression, endothelial cell migration and capillary tube formation.
Guruvayoorappan C; Kuttan G
J Exp Ther Oncol; 2007; 6(3):241-50. PubMed ID: 17552364
[TBL] [Abstract][Full Text] [Related]
15. Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators.
Hamsa TP; Kuttan G
Drug Chem Toxicol; 2012 Jan; 35(1):57-70. PubMed ID: 22145808
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of angiogenesis by interleukin-4 gene therapy in rat adjuvant-induced arthritis.
Haas CS; Amin MA; Allen BB; Ruth JH; Haines GK; Woods JM; Koch AE
Arthritis Rheum; 2006 Aug; 54(8):2402-14. PubMed ID: 16869003
[TBL] [Abstract][Full Text] [Related]
17. Alternative splicing of vasohibin-1 generates an inhibitor of endothelial cell proliferation, migration, and capillary tube formation.
Kern J; Bauer M; Rychli K; Wojta J; Ritsch A; Gastl G; Gunsilius E; Untergasser G
Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):478-84. PubMed ID: 18187668
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
Roccaro AM; Hideshima T; Raje N; Kumar S; Ishitsuka K; Yasui H; Shiraishi N; Ribatti D; Nico B; Vacca A; Dammacco F; Richardson PG; Anderson KC
Cancer Res; 2006 Jan; 66(1):184-91. PubMed ID: 16397231
[TBL] [Abstract][Full Text] [Related]
19. Antiangiogenic activity of 11,11'-dideoxyverticillin, a natural product isolated from the fungus Shiraia bambusicola.
Chen Y; Zhang YX; Li MH; Zhao WM; Shi YH; Miao ZH; Zhang XW; Lin LP; Ding J
Biochem Biophys Res Commun; 2005 Apr; 329(4):1334-42. PubMed ID: 15766573
[TBL] [Abstract][Full Text] [Related]
20. mTOR inhibitor RAD001 (everolimus) has antiangiogenic/vascular properties distinct from a VEGFR tyrosine kinase inhibitor.
Lane HA; Wood JM; McSheehy PM; Allegrini PR; Boulay A; Brueggen J; Littlewood-Evans A; Maira SM; Martiny-Baron G; Schnell CR; Sini P; O'Reilly T
Clin Cancer Res; 2009 Mar; 15(5):1612-22. PubMed ID: 19223496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
